Peptide T and glucose metabolism in AIDS dementia complex

Journal of Nuclear Medicine

Volumn 37, Issue 7, 1996, Pages 1177-1180

  Villemagne, Victor L ^b   Phillips, Robert L ^b   Liu, Xiang ^b   Gilson, Stephen F ^b   Dannals, Robert F ^b   Wong, Dean F ^b   Harris, Pamela J ^b   Ruff, Michael ^b   Pert, Candace ^b   Bridge, Peter ^b   London, Edythe D ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NONE

Author keywords

AIDS dementia; brain imaging; glucose metabolism; peptide T

Indexed keywords

ACICLOVIR; CIPROFLOXACIN; CLOFAZIMINE; COTRIMOXAZOLE; ETHAMBUTOL; FLUORODEOXYGLUCOSE F 18; FOLIC ACID; MULTIVITAMIN; PEPTIDE T; RIFAMPICIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ARTICLE; BRAIN METABOLISM; CASE REPORT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; GLUCOSE METABOLISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIMBIC SYSTEM; MALE; NEUROLOGICAL COMPLICATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AIDS DEMENTIA COMPLEX; BRAIN; CASE-CONTROL STUDIES; DEOXYGLUCOSE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; PEPTIDE T; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 10144227047     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19:517-524.
2. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex. I. Neuropathology. Ann Neurol 1986;19:525-535.
3. Price RW, Brew B, Sidtis J. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988;239:586-592.
4. Hill JM, Ruff MR, Pert CB. AIDS as a neuropeptide disorder: Peptide T, VIP and the HIV receptor. Psychopharmacol Bull 1988;24:315-319.
5. Buzy JM, Brenneman DE, Siegal FP, Ruff MR, Pert CB. Cerebrospinal fluid from cognitively impaired patient with acquired immunodeficiency syndrome shows gp120-like neuronal killing in vitro. Am J Med 1989;87:361-362.
6. Pert CB, Smith CC, Ruff RM, Hill JM. AIDS and its dementia as a neuropeptide disorder: role of VIP receptor blockade by human immunodeficiency virus (HIV) envelope. Ann Neurol 1988;23:S71-S73.
7. Ruff MR, Martin BM, Ginns EI, Farrar WL, Pert CB. CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxis: relationship to vasoactive intestinal polypeptide. FEBS Lett 1987;211:17-22.
8. Bridge PT, Heseltine PNR, Parker ES, et al. Improvement in AIDS patients on peptide T. Lancet 1989;226-227.
9. Bridge PT, Heseltine PNR, Parker ES, et al. Results of extended peptide T administration in AIDS and ARC patients. Psychopharmacol Bull 1991;27:237-245.
10. 18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 1979;44:127-137.
11. 18F]2-fluoro-2-deoxy-D-glucose. Validation of method. Ann Neurol 1979;6:371-388.
12. Horwitz B, Grady CL, Schlageter NL, Duara R, Rapoport SI. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease. Brain Res 1987;407: 294-306.
13. Kuhl DE, Metter EJ, Riege WH, Markham CH. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease. Ann Neurol 1984;15:S119-S125.
14. Kuhl DE, Metter EJ, Riege WH. Patterns of cerebral glucose utilization in depression, multiple infarct dementia and Alzheimer's disease. Res Publ Assoc Res Nerv Ment Dis 1985;63:211-226.
15. Rottenberg DA, Moeller JR, Strother SC, et al. The metabolic pathology of the AIDS dementia complex. Ann Neurol 1987;22:700-706.
16. van Gorp WG, Mandelkern MA, Gee M, Hinkin CH, et al. Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia. J Neuropsychiatry Clin Neurosci 1992;4:280-287.
17. Pascal S, Resnick L, Barker WW, et al. Metabolic assymetries in asymptomatic HIV-1 seropositive subjects: relationship to disease onset and MRI findings. J Nucl Med 1991;32:1725-1729.
18. Brunetti A, Berg G, Di Chiro G, et al. Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3′-azido-2′,3′-dideoxythymidine (AZT, zidovudine): a PET-FDG study. J Nucl Med 1989;30:581-590.
19. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980;238:E69-E82.
20. Rasband WS. Image: image processing and analysis. Rockville: National Institutes of Health, Research Services Branch; 1990.
21. Brenneman DE, Westbrook GL, Fitzgerald SP, et al. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 1988;335:639-642.
22. Kimes AS, London ED, Szabo G, Raymon L, Tabakoff B. Reduction of cerebral glucose utilization by the HIV envelope glycoprotein gp120. Exp Neurol 1991;112: 224-228.
23. Pert CB, Hill JM, Ruff RM, et al. Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity. Proc Natl Acad Sci USA 1986;83:9254-9258.
24. Pulliam L, West D, Haigwood N, Swanson RA. HIV-1 envelope protein gp120 alters astrocytes in human brain cultures. AIDS Res Hum Retroviruses 1993;5:439-444.
25. Ketzler S, Weis S, Haug H, Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol 1990;80:92-94.
26. Kuhl DE, Markham CH, Metter EJ, Riege WH, Phelps ME, Mazziotta JC. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease. Res Publ Assoc Res Nerv Ment Dis 1985;63:199-210.